Locations:
SearchPlease join our staff as we participate or present in the following oral and poster presentations at the 2017 ASTRO Annual Meeting
H&N 3 – Novel Approaches to the Treatment of Oropharynx Cancer
Room 11 A/B
11AM
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Oral
Yvonne Pham, MD
Impact of Smoking on Outcomes in HPV+ Oropharynx Cancer: It′s More than Pack-Years
Biology 7 – Sensitizers, Response, and Models
Room 2
1:30PM
Oral
Brian Yard, MD
Systematic Annotation of Genetic Variants That Confer Resistance to Radiation: A Pan-Cancer Encyclopedia
Head and Neck ePoster Discussion
Hall A-B1, Ground Level
1:30PM
ePoster
Matthew Ward, MD
A Nomogram to Predict Severe Late Toxicity after Definitive Reirradiation for Squamous Carcinoma of the Head and Neck
CNS 2 – Brain and Spine Metastases and Treatment Related Toxicity
Room 2
3:15PM
Oral
Aditya Juloori, MD
Use of Concurrent TKIs with SRS is Associated with an Increased Rate of Radiation Necrosis among Patients with Renal Cell Carcinoma Brain Metastasis
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients